105 related articles for article (PubMed ID: 11720457)
21. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
22. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
23. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy for stage III colon cancer: does timing matter?
Czaykowski PM; Gill S; Kennecke HF; Gordon VL; Turner D
Dis Colon Rectum; 2011 Sep; 54(9):1082-9. PubMed ID: 21825887
[TBL] [Abstract][Full Text] [Related]
25. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
26. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
Wright JD; Gibb RK; Geevarghese S; Powell MA; Herzog TJ; Mutch DG; Grigsby PW; Gao F; Trinkaus KM; Rader JS
Cancer; 2005 Jan; 103(1):85-91. PubMed ID: 15540239
[TBL] [Abstract][Full Text] [Related]
27. A study of lymph node ratio as a prognostic marker in colon cancer.
Derwinger K; Carlsson G; Gustavsson B
Eur J Surg Oncol; 2008 Jul; 34(7):771-5. PubMed ID: 18079086
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer.
Wind J; ten Kate FJ; Kiewiet JJ; Lagarde SM; Slors JF; van Lanschot JJ; Bemelman WA
Eur J Surg Oncol; 2008 Apr; 34(4):390-6. PubMed ID: 17614246
[TBL] [Abstract][Full Text] [Related]
29. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
30. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
31. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
[TBL] [Abstract][Full Text] [Related]
32. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
33. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
[TBL] [Abstract][Full Text] [Related]
34. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant treatment for elderly patients with colon cancer. An observational study.
Pasetto LM; Falci C; Basso U; Gasparini G; D'Andrea M; Bonginelli P; Bajetta E; Platania M; Alabiso O; Miraglia S; Bertona E; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Negru ME; Luchena G; Giordano M; Buzzi F; Ricottao R; Sienao S; Monfardini S
Anticancer Res; 2008; 28(4C):2513-8. PubMed ID: 18751443
[TBL] [Abstract][Full Text] [Related]
36. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
Barton MB; Gabriel GS; Miles S
ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
[TBL] [Abstract][Full Text] [Related]
38. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
39. Undertreatment strongly decreases prognosis of breast cancer in elderly women.
Bouchardy C; Rapiti E; Fioretta G; Laissue P; Neyroud-Caspar I; Schäfer P; Kurtz J; Sappino AP; Vlastos G
J Clin Oncol; 2003 Oct; 21(19):3580-7. PubMed ID: 12913099
[TBL] [Abstract][Full Text] [Related]
40. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
